FDA Approves MEFENAMIC ACID — Micro Labs Limited

Micro Labs Limited has obtained regulatory approval for Mefenamic Acid oral tablets, opening a new avenue for the Indian generics maker to address inflammatory pain markets. This ANDA090562 clearance signals the company’s continued expansion into the US generic landscape, intensifying competition within the non-steroidal anti-inflammatory drug (NSAID) sector.